Literature DB >> 28428703

Comparative Study of Two ELISA Kits for Estimation of Antibodies to Hepatitis B Virus in Human Normal Immunoglobulin and Specific Immunoglobulin Intended for Intravenous or Intramuscular Use.

J P Prasad1, Y Madhu1, Arushi Mandhan1, Payal Garg1, Anu Prakash1, Varsha Singh1, Daud Ali1, Prdeep Kumar1, Surinder Singh1, G R Soni1, Varun Singh1.   

Abstract

Current study is conducted to evaluate method verification of two locally available kits manufactured by DSI & BIORAD for quantitative estimation of Hepatitis B virus antibodies in human normal immunoglobulin by using International standard of National Institute of Biological Standards and Control. Four analyst perform five sets of test in duplicate analysing accuracy, precision, and limit of detection, sensitivity and specificity. Our results suggest that both DSI and BIORAD kits fulfil the validation criteria and are sensitive to detect up to 10 mIU concentration precisely and accurately. DSI kit is more precise at concentration 100 mIU and economically 4-5 times cheaper in local market; on the other hand, BIORAD kits provide larger detection range up to 1000 mIU.

Entities:  

Keywords:  Accuracy; Hepatitis B virus; Immunoglobulin; Limit of detection; Precision; Sensitivity; Specificity

Year:  2016        PMID: 28428703      PMCID: PMC5382075          DOI: 10.1007/s12291-016-0590-9

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  7 in total

Review 1.  Supply, use, and abuse of intravenous immunoglobulin.

Authors:  A Nowak-Wegrzyn; H M Lederman
Journal:  Curr Opin Pediatr       Date:  1999-12       Impact factor: 2.856

2.  Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%).

Authors:  M Ballow; M Berger; F A Bonilla; R H Buckley; C H Cunningham-Rundles; P Fireman; M Kaliner; H D Ochs; S Skoda-Smith; M T Sweetser; H Taki; C Lathia
Journal:  Vox Sang       Date:  2003-04       Impact factor: 2.144

3.  Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids.

Authors:  E J COHN; L E STRONG
Journal:  J Am Chem Soc       Date:  1946-03       Impact factor: 15.419

4.  An immune globulin intravenous (human), 10% liquid privigen: for the treatment of primary immunodeficiency diseases.

Authors: 
Journal:  P T       Date:  2009-06

Review 5.  Intravenous immune globulin in autoimmune and inflammatory diseases.

Authors:  Erwin W Gelfand
Journal:  N Engl J Med       Date:  2012-11-22       Impact factor: 91.245

6.  Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier.

Authors:  Isabelle St-Amour; Isabelle Paré; Wael Alata; Katherine Coulombe; Cassandra Ringuette-Goulet; Janelle Drouin-Ouellet; Milène Vandal; Denis Soulet; Renée Bazin; Frédéric Calon
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-18       Impact factor: 6.200

Review 7.  Primary immunodeficiencies.

Authors:  Megan A Cooper; Thomas L Pommering; Katalin Korányi
Journal:  Am Fam Physician       Date:  2003-11-15       Impact factor: 3.292

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.